A comprehensive view of GoodRx Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

GoodRX reports Q3 net loss increases to US$41.7M from US$18.1M a year ago impacted by US$29.0M stock-based compensation expense; revenue down 4% year-over-year to US$187.3M as firm sees double-digit growth in subscriptions, drug-maker solutions platforms

New report from GoodRx shows positive impact of giving pharmacists the power to prescribe; 37 million people live in under-resourced areas, expanding pharmacist prescriber authority could boost access to healthcare

GoodRx completes US$150M acquisition of medication technology, services platform vitaCare, with a US$7M consideration contingent payment based on vitaCare’s 2023 financial performance

GoodRx acquires vitaCare Prescription Services for US$150M to improve patient access and drug adherence, expects deal to close mid-2022; only half of 500 million prescriptions in US filled yearly because of cost, with 29% of patients experiencing delays

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count